TriRx completes Elanco site buy

Connecticut-based CDMO TriRx Pharmaceutical Services has finalized and closed on an agreement to buy Elanco Animal Health’s site in Speke, near Liverpool, UK. The two companies had agreed a two-facility sale and long-term supply agreement in 2021, covering this site and another in Shawnee, Kansas, which it took over last August.

TriRx officially took ownership of the Speke facility on 1 February. A formal celebration event took place on 8 February, attended by the local MP, Maria Eagle, other local dignitaries, key customers, pharmaceutical executives, personnel from both firms and local community members.

Originally built by Eli Lilly, Speke can manufacture both human and animal health products. The approximately 350 employees will all transfer, bringing TriRx’s total number of sites to five, with two manufacturing facilities in North America and two in Europe.